ENZN Financial Facts

Net (loss) income: -4.61M
Weighted average shares - diluted (in Shares): -88.33M
See Full Income Statement

Accumulated deficit: 149.85M
Total stockholders’ equity: -51.49M
See Full Balance Sheet

Enzon Pharmaceuticals Inc. (ENZN) Earnings

  |   Expand Research on ENZN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate 0.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -4.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/14/25 Q225 N/AN/A N/A N/AN/A N/A N/A N/A
11/18/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
11/12/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/19/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/12/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/7/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/27/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A